Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...
Mock-jury participants favored the plaintiff less often with AI-assisted double reads than with single reads, implying AI workflow design can meaningfully influence perceived radiologist culpability.
Incidence of acute leukemia in pregnancy is extremely low, symptoms overlap with gestation, and delayed diagnosis amplifies the need for coordinated hematology–maternal-fetal management. A 23-patient ...
This letter refutes the “overdiagnosis” narrative, blaming the stimulant shortage on DEA regulatory failures, clinical constraints, and recognition of historical underdiagnosis. By concluding that ...
Persistence of high EBNA-1 titers across longitudinal samples was characteristic of MS, whereas MOGAD and NMOSD generally exhibited titer attenuation during follow-up. High-level EBNA-1 positivity in ...
The authors of “Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage” reply to a letter to the editor. We welcome the input and opportunity for discussion. There is much on which we can ...
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual immunotherapy. This episode, titled Dual Immunotherapy Strategies in Metastatic ...
Clinicians weigh dual immunotherapy vs monotherapy in metastatic NSCLC, comparing CheckMate 227 and POSEIDON efficacy, PD‑L1 subsets, and toxicity. The oncologists examined deveral pivotal trials ...
As Medicare Advantage grows, first-time enrollees demonstrate increasing demographic and clinical diversity, indicating that benefits should be designed to reflect the population’s changing ...
Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
As Medicare Advantage grows, first-time enrollees demonstrate increasing demographic and clinical diversity, indicating that benefits should be designed to reflect the population’s changing ...
Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results